Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (KCT0012789) titled 'Clinical Study Comparing the Skin Improvement Effects of Curecode Melacalm Serum and a Control Product' on Oct. 19.
Study Type: Interventional Study
Study Design:
Primary Purpose : Other(Evaluation of cosmetic skin improvement efficacy), Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Dr. Raymond Lab Inc
Condition:
Factors influencing health status and contact with health services
Intervention:
Others(COSMETIC) : Participants in the test group applied an appropriate amount of Curecode Melacalm Serum to the face twice daily, morning and evening, for 4 weeks. Participants ...